A detailed history of Peoples Bank/Ks transactions in Biogen Inc. stock. As of the latest transaction made, Peoples Bank/Ks holds 30 shares of BIIB stock, worth $5,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$5,213
Previous $6.95 Million 16.38%
% of portfolio
0.0%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 30, 2023

BUY
$253.3 - $285.89 $7,599 - $8,576
30 New
30 $7.71 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Peoples Bank/Ks Portfolio

Follow Peoples Bank/Ks and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peoples Bank/Ks, based on Form 13F filings with the SEC.

News

Stay updated on Peoples Bank/Ks with notifications on news.